Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum Helicobacter pylori antibody reactivity in seven Asian countries using an automated latex aggregation turbidity assay.
Akada J, Tshibangu-Kabamba E, Tuan VP, Kurogi S, Matsuo Y, Ansari S, Doohan D, Phuc BH, Subsomwong P, Waskito LA, Binh TT, Nguyen LT, Khien VV, Dung HDQ, Miftahussurur M, Syam AF, Tshering L, Vilaichone RK, Mahachai V, Ratanachu-Ek T, Shrestha PK, Yee TT, Htet K, Aftab H, Matsuhisa T, Uchida T, Okimoto T, Mizukami K, Kodama M, Murakami K, Takahashi N, Yamaoka Y. Akada J, et al. Among authors: kurogi s. J Gastroenterol Hepatol. 2021 Aug;36(8):2198-2209. doi: 10.1111/jgh.15467. Epub 2021 Mar 9. J Gastroenterol Hepatol. 2021. PMID: 33609333
Early response in phosphorylation of ribosomal protein S6 is associated with sensitivity to trametinib in colorectal cancer cells.
Hirashita Y, Tsukamoto Y, Kudo Y, Kakisako D, Kurogi S, Hijiya N, Nakada C, Uchida T, Hirashita T, Hiratsuka T, Akagi T, Ueda Y, Shiroshita H, Etoh T, Mizukami K, Honda K, Okimoto T, Kodama M, Inomata M, Moriyama M, Murakami K. Hirashita Y, et al. Among authors: kurogi s. Lab Invest. 2021 Aug;101(8):1036-1047. doi: 10.1038/s41374-021-00590-w. Epub 2021 Apr 28. Lab Invest. 2021. PMID: 33911189 Free article.
Efficient Establishment of Bile-Derived Organoids From Biliary Cancer Patients.
Kinoshita K, Tsukamoto Y, Hirashita Y, Fuchino T, Kurogi S, Uchida T, Nakada C, Matsumoto T, Okamoto K, Motomura M, Fukuchi S, Sagami R, Nagai T, Gotoh Y, Fukuda K, Ogawa R, Mizukami K, Okimoto T, Kodama M, Murakami K, Moriyama M, Hijiya N. Kinoshita K, et al. Among authors: kurogi s. Lab Invest. 2023 Jun;103(6):100105. doi: 10.1016/j.labinv.2023.100105. Epub 2023 Feb 7. Lab Invest. 2023. PMID: 36842278 Free article.
Characterization of residual cancer by comparison of a pair of organoids established from a patient with esophageal squamous cell carcinoma before and after neoadjuvant chemotherapy.
Fuchino T, Kurogi S, Tsukamoto Y, Shibata T, Fumoto S, Fujishima H, Kinoshita K, Hirashita Y, Fukuda M, Nakada C, Itai Y, Suzuki K, Uchida T, Shiroshita H, Matsumoto T, Yamaoka Y, Tsutsumi K, Fukuda K, Ogawa R, Mizukami K, Kodama M, Inomata M, Murakami K, Moriyama M, Hijiya N. Fuchino T, et al. Among authors: kurogi s. Hum Cell. 2024 Mar;37(2):491-501. doi: 10.1007/s13577-023-01020-3. Epub 2024 Jan 6. Hum Cell. 2024. PMID: 38184488
Enhanced phosphorylation of c-Jun by cisplatin treatment as a potential predictive biomarker for cisplatin response in combination with patient-derived tumor organoids.
Tsukamoto Y, Kurogi S, Shibata T, Suzuki K, Hirashita Y, Fumoto S, Yano S, Yanagihara K, Nakada C, Mieno F, Kinoshita K, Fuchino T, Mizukami K, Ueda Y, Etoh T, Uchida T, Hanada T, Takekawa M, Daa T, Shirao K, Hironaka S, Murakami K, Inomata M, Hijiya N, Moriyama M. Tsukamoto Y, et al. Among authors: kurogi s. Lab Invest. 2022 Dec;102(12):1355-1366. doi: 10.1038/s41374-022-00827-2. Epub 2022 Aug 3. Lab Invest. 2022. PMID: 35922477 Free article.
Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor.
Amada K, Hijiya N, Ikarimoto S, Yanagihara K, Hanada T, Hidano S, Kurogi S, Tsukamoto Y, Nakada C, Kinoshita K, Hirashita Y, Uchida T, Shin T, Yada K, Hirashita T, Kobayashi T, Murakami K, Inomata M, Shirao K, Aoki M, Takekawa M, Moriyama M. Amada K, et al. Among authors: kurogi s. Cancer Sci. 2023 May;114(5):2189-2202. doi: 10.1111/cas.15735. Epub 2023 Feb 9. Cancer Sci. 2023. PMID: 36694355 Free PMC article.
Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response.
Tsukamoto Y, Hirashita Y, Shibata T, Fumoto S, Kurogi S, Nakada C, Kinoshita K, Fuchino T, Murakami K, Inomata M, Moriyama M, Hijiya N. Tsukamoto Y, et al. Among authors: kurogi s. Cancers (Basel). 2023 Aug 15;15(16):4104. doi: 10.3390/cancers15164104. Cancers (Basel). 2023. PMID: 37627132 Free PMC article. Review.
Association of immune-related expression profile with sensitivity to chemotherapy in esophageal squamous cell carcinoma.
Tsukamoto Y, Kurogi S, Fujishima H, Shibata T, Fumoto S, Nishiki K, Suzuki K, Etoh T, Shiraishi N, Fuchino T, Hirashita Y, Nakada C, Uchida T, Inomata M, Moriyama M, Hijiya N. Tsukamoto Y, et al. Among authors: kurogi s. Cancer Sci. 2023 Nov;114(11):4459-4474. doi: 10.1111/cas.15942. Epub 2023 Sep 15. Cancer Sci. 2023. PMID: 37715346 Free PMC article.
Overexpression of VSNL1 Enhances Cell Proliferation in Colorectal Carcinogenesis.
Aiba T, Hijiya N, Akagi T, Tsukamoto Y, Hirashita Y, Kinoshita K, Uchida T, Nakada C, Kurogi S, Ueda Y, Shiroshita H, Shiraishi N, Murakami K, Inomata M, Moriyama M. Aiba T, et al. Among authors: kurogi s. Pathobiology. 2024;91(2):121-131. doi: 10.1159/000533877. Epub 2023 Oct 5. Pathobiology. 2024. PMID: 37797604
36 results